Description

Dicyclomine 10 mg + Simethicone 40 mg Suspension combines an antispasmodic agent with an anti-foaming agent to help manage abdominal discomfort associated with intestinal spasms and excessive gas.

Dicyclomine helps relax intestinal smooth muscle and reduce spasms, while Simethicone helps reduce discomfort caused by gas and bloating by facilitating the coalescence and elimination of gas bubbles.

The suspension dosage form provides a convenient option when liquid medication is preferred, subject to the prescribing healthcare professional’s advice.

Key Benefits

• Combines Dicyclomine 10 mg and Simethicone 40 mg.
• Helps relieve abdominal cramps associated with intestinal spasms.
• Helps reduce gas-related bloating and abdominal discomfort.
• Convenient liquid suspension dosage form.
• Suitable addition to gastroenterology and digestive-care portfolios.
• Can be positioned within a gastro pharma franchise product range.

Composition

Each suitable dose contains:

• Dicyclomine Hydrochloride – 10 mg
• Simethicone – 40 mg
• Suitable suspension base – q.s.

Exact composition should be confirmed against the final approved product specification and marketed pack.

Indications / Uses

The combination may be prescribed for symptomatic relief of:

• Abdominal cramps
• Intestinal spasms
• Gas-related abdominal discomfort
• Bloating associated with excessive intestinal gas
• Functional gastrointestinal discomfort, when clinically appropriate

Use should be based on the patient’s age, symptoms and medical assessment.

Dosage Form

Oral Suspension

Shake well before use and administer according to the dosage prescribed by the healthcare professional.

Packaging

Available in a convenient oral suspension bottle, subject to the final marketed pack configuration.

Pharma Franchise Opportunity

Dicyclomine 10 mg + Simethicone 40 mg Suspension can be included in a gastro pharma franchise portfolio targeting physicians, pediatricians, gastroenterologists, clinics and healthcare institutions.

Its combination of antispasmodic and anti-gas action makes it a relevant product for a digestive-care and gastrointestinal-focused PCD pharma franchise range.

Why Choose Dicyclomine + Simethicone Suspension?

• Combination of antispasmodic and anti-gas therapy
• Convenient oral suspension format
• Suitable for digestive and gastrointestinal product portfolios
• Useful addition to a gastroenterology-focused product range
• Potential fit for PCD pharma franchise and third-party pharmaceutical portfolios